Eurofins is the world leader in the bio/pharmaceutical testing market. With over €6.95 billion in annual revenues and 65,000 employees across 950 sites in 60 countries, Eurofins is a leading international group of laboratories providing an unparalleled range of testing and support services to the biopharmaceutical, food, and environmental industries.
The Eurofins BioPharma Product Testing (BPT) Group is the largest network of harmonized bio/pharmaceutical GMP product testing laboratories worldwide. Eurofins BPT provides comprehensive CMC laboratory services for the world’s largest pharmaceutical and biopharmaceutical companies. The service portfolio supports all stages of the drug development process and all functional areas of bio/pharmaceutical manufacturing, including method development, microbiology, process validation and quality control.
The Biosafety Senior Scientific Advisor (SSA) serves as the primary technical authority for Eurofins BPT, providing strategic guidance to clients and internal leadership on GMP Biosafety requirements. This role covers the full lifecycle of biologics, including Cell Bank Production/Characterization, Viral Clearance, and Unprocessed Bulk lot release.
The SSA operates as a high-level subject matter expert, partnering with field sales to identify client needs, architect technical solutions, and secure new business. This position requires a blend of scientific depth and commercial acumen to position Eurofins as the premier partner for sponsors and CDMOs.
Biosafety Senior Scientific Advisor responsibilities include, but are not limited to, the following:
Strategic Market Leadership & Partnerships
Business Development & Execution
Network & Operational Alignment
The ideal candidate would possess:
Basic Minimum Qualifications
Location of the position is flexible with requirement of close access to a major airport.
Schedule:
What we offer:
Eurofins USA BioPharma Services is a Disabled and Veteran Equal Employment Opportunity employer.

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories.
Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.
Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.